News

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
Jim Cramer is Confident “Someone Will Want Some of Kenvue”
Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Rediff Money12h
India's 1st Cough Clinics Launched by Kenvue & API
Kenvue and API launch India's first Cough Clinics to improve cough diagnosis and treatment. The initiative aims to address ...
6KVUE : Assessing Kenvue: Insights From 6 Financial Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Explore more
Business Wire4d
Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
Barchart on MSN2d
Kenvue's Q2 2025 Earnings: What to Expect
Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip.